The incidence of sudden death in post-myocardial infarction beta-blocker trials

J Clin Pharm Ther. 1999 Aug;24(4):237-9. doi: 10.1046/j.1365-2710.1999.00232.x.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Clinical Trials as Topic
  • Death, Sudden / epidemiology*
  • Humans
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / mortality*

Substances

  • Adrenergic beta-Antagonists